TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

AVANTI RESEARCH

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

AVANTI RESEARCH

ST13

US500000079413997

Classe

1, 5, 9

Pedido

79413997

Registro

7895563

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

25

Atualização mais recente

19/06/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9

Data de depósito

23/07/2024

Data de registro

19/08/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

19/08/2025

Última transação

19/06/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

GB

Examinador

DELGIZZI, RONALD ERNEST

Unidade examinadora

L70

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Croda International Plc

Representantes

Patrick J. Jennings Pillsbury Winthrop Shaw Pittman, LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical compounds in the nature of lipids and lipid mixtures for scientific or research use other than for medical use; lipid compounds for scientific or research use other than for medical use; adjuvants, polymers and excipients, namely, surfactants, dispersants, diluents, disintegrants, emulsifiers, binders, stabilisers and fillers, for scientific or research use other than for medical use; transfection reagents for scientific or research use other than for medical use; chemical reagents for the delivery of lipids for scientific or research use other than for medical use; standard solutions in the nature of lipids and lipid mixtures for use with analytical techniques, namely, mass spectrometry other than for medical use; lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labelled lipids, oxidized lipids, lipid extracts from natural sources, biological compounds conjugated with modified gold particles for all being for scientific or research use other than for medical use; fatty acids, glycerolipids, glycerophospholipids, sphingolipids, glycosphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies, all being for scientific or research use other than for medical use; amino acids, peptides, nucleosides, nucleotides and sugars, and lipid conjugated versions of the aforesaid, all being for scientific or research use other than for medical use; diagnostic and analytical reagents for scientific or research use other than for medical use; formulations in the nature of liposomes, pre-mixed lipid blends and lipids for bicelle formation comprising lipids for scientific or research use other than for medical use; enzymes for scientific or research use; fluorophores and fluorescent probes for scientific or research use other than for medical use; chemical auxiliary agents as raw materials for manufacturing pharmaceutical preparations, nutrient preparations, and food supplements

Classe 5

Lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labelled lipids, oxidized lipids, lipid extracts from natural sources, biological compounds conjugated with modified gold particles, fatty acids, glycerolipids, glycerophospholipids, sphingolipids, glycosphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies, active agents, additives, and excipients in pharmaceutical preparations; adjuvants, polymers and excipients, namely, surfactants, dispersants, diluents, disintegrants, emulsifiers, binders, stabilisers and fillers, all of the aforesaid being for pharmaceutical or medical use; immunostimulatory compounds for pharmaceutical or medical use; isotopes for medical use; transfection reagents for pharmaceutical or medical use; amino acids, peptides, nucleosides, nucleotides and sugars, and lipid conjugated versions of the aforesaid, all being for pharmaceutical or medical use; drug delivery auxiliary agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Classe 9

Apparatus and instruments for scientific research in laboratories, namely, extruders, membranes and parts therefor

Publicações

Histórico de despachos e eventos da marca no USPTO.

25 publicações encontradas

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

18/06/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/06/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

31/05/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

26/03/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/03/2026

FIMP

FINAL DISPOSITION PROCESSED

05/03/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

20/11/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

19/08/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

19/08/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/07/2025

PUBO

PUBLISHED FOR OPPOSITION

01/07/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

25/06/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

30/05/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

29/05/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

29/05/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

29/05/2025

RFNT

REFUSAL PROCESSED BY IB

29/03/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/03/2025

RFRR

REFUSAL PROCESSED BY MPU

10/03/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

22/01/2025

CNRT

NON-FINAL ACTION WRITTEN

21/01/2025

DOCK

ASSIGNED TO EXAMINER

13/01/2025

MAFR

APPLICATION FILING RECEIPT MAILED

10/01/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/01/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/01/2025

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace AVANTI RESEARCH ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.